Sickle Cell Disease
An inherited genetic blood disorder where abnormal hemoglobin causes red blood cells to become sickle-shaped, leading to severe pain episodes, chronic anemia, and organ damage.
Emergency Management: Acute Chest Syndrome: Requires immediate broad-spectrum IV antibiotics, oxygen, aggressive pain control, and urgent Simple or Exchange Blood Transfusion to lower HbS% to < 30%.
Sickle cell disease (SCD) is a group of inherited autosomal recessive red blood cell disorders characterized by the presence of an abnormal hemoglobin, hemoglobin S (HbS). In homozygous individuals (HbSS), deoxygenation leads to HbS polymerization, causing erythrocytes to assume a rigid, sickle-like shape, leading to vaso-occlusion, severe pain, chronic hemolytic anemia, and cumulative organ damage.
Detailed Overview
SCD is the most common inherited blood disorder in the United States. The rigid, sickled red blood cells cause microvascular occlusion resulting in tissue ischemia and excruciating pain crises. Constant hemolysis leads to chronic anemia, jaundice, and gallstones. Over time, recurrent vaso-occlusion causes end-organ infarction, most notably autosplenectomy in childhood, rendering patients highly susceptible to encapsulated bacteria. Management focuses on preventing polymerization with Hydroxyurea, aggressive management of pain crises, and potentially curative hematopoietic stem cell transplantation or gene therapy.
Epidemiology & Demographics
Affects approximately 100,000 Americans, predominantly those of sub-Saharan African descent. Occurs in 1 out of every 365 Black or African American births. The sickle cell trait (HbAS) protects against severe Plasmodium falciparum malaria, driving its evolutionary preservation in endemic areas.
Etiological Mechanism
Caused by a single point mutation in the beta-globin gene (HBB) on chromosome 11, where glutamic acid is replaced by valine at the 6th position of the beta chain. Homozygosity (HbSS) causes Sickle Cell Anemia. Heterozygous compound states (HbSC, HbS-beta thalassemia) also cause the disease but with varying severities.
Primary Causes
Inheritance of two abnormal HBB genes (at least one being the HbS allele)
Normal HbA remains soluble when deoxygenated. Mutant HbS, due to the hydrophobic valine substitution, undergoes conformational changes upon deoxygenation, exposing a sticky patch that binds to other HbS molecules. This forms long, rigid polymers that distort the RBC into a sickle shape. Initially reversible upon reoxygenation, repeated cycles damage the RBC membrane, leading to irreversible sickling. These rigid cells increase blood viscosity, damage the vascular endothelium, and mechanically obstruct post-capillary venules (Vaso-Occlusive Crisis). Furthermore, the damaged RBC membranes cause premature destruction by macrophages in the spleen (extravascular hemolysis) and direct intravascular lysis, liberating free hemoglobin which scavenges nitric oxide, causing systemic vasoconstriction and pulmonary hypertension.
Diagnostic Criteria & Guidelines
Universal newborn screening in the US via Isoelectric Focusing or High-Performance Liquid Chromatography (HPLC). Confirmed by Hemoglobin Electrophoresis showing absence of HbA, dominance of HbS (>85%), and variable HbF.
Preventative: Hydroxyurea 15-35 mg/kg PO daily (increases HbF, diluting HbS and preventing polymerization). Folic acid 1 mg PO daily. Prophylactic Penicillin V 125-250 mg PO BID from 2 months to 5 years of age. Routine vaccinations including Pneumococcal.
Second-Line & Adjunctive Therapy
Disease Modifying: L-glutamine, Crizanlizumab (P-selectin inhibitor), or Voxelotor (HbS polymerization inhibitor). Curative: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for children with matched sibling donors. Emerging Gene Therapies (e.g., Exa-cel / Casgevy) using CRISPR to reactivate fetal hemoglobin.
Surgical & Procedural Management
Cholecystectomy for symptomatic pigment gallstones. Total hip arthroplasty for severe avascular necrosis of the femoral head.
Patient Counseling & Advice
Instruct parents of infants to seek immediate emergency care for ANY fever > 101.3F (38.5C) due to the risk of fatal pneumococcal sepsis. Educate on the importance of strict adherence to Hydroxyurea to prevent long-term organ damage.
Follow-Up & Monitoring Schedule
Comprehensive clinic visits every 3-6 months. Annual TCD until age 16. Annual screening for microalbuminuria, retinopathy (eye exam), and pulmonary hypertension (Echocardiogram).
Preventive Strategies
Genetic counseling for prospective parents with sickle cell trait. Prenatal diagnosis via chorionic villus sampling or amniocentesis.
Life expectancy has improved from 14 years (in 1970) to the mid-40s and 50s today. Major causes of mortality are Acute Chest Syndrome, sudden death from arrhythmias, and end-stage renal disease.